Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Balance | $ 579,026 | $ 430,882 |
| Acquisitions (Note 2) | 19,096 | 147,484 |
| Prior year acquisitions | 1,809 | |
| Currency translation | (232) | (1,149) |
| Balance | 597,890 | 579,026 |
| Biotechnology [Member] | ||
| Balance | 254,930 | 108,723 |
| Acquisitions (Note 2) | 16,186 | 147,484 |
| Prior year acquisitions | ||
| Currency translation | 759 | (1,277) |
| Balance | 271,875 | 254,930 |
| Protein Platforms [Member] | ||
| Balance | 220,826 | 218,889 |
| Acquisitions (Note 2) | ||
| Prior year acquisitions | 1,809 | |
| Currency translation | (815) | 128 |
| Balance | 220,011 | 220,826 |
| Diagnostics [Member] | ||
| Balance | 103,270 | 103,270 |
| Acquisitions (Note 2) | 2,910 | |
| Prior year acquisitions | ||
| Currency translation | (176) | |
| Balance | $ 106,004 | $ 103,270 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|